Skip to Main Content
Pharmacist's Letter Canada
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • New Drugs
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Guide to Cannabis training for pharmacists that offers 16 hours of ACPE-accredited training based on the latest, science-based cannabis research. Only $199. Learn More!
  1. Home
  2. Browse
  3. Cardiology
  4. Antithrombotics
  5. Treatment
  6. Other

Other

  • Angina (14)
  • Antithrombotics (367)
    • Drug-Induced Thrombosis (32)
    • Prevention (38)
    • Reversal (15)
    • Treatment (336)
      • Apixaban (Eliquis) (86)
      • Aspirin (179)
      • Clopidogrel (Plavix) (116)
      • Dabigatran (Pradaxa) (113)
      • Edoxaban (Savaysa) (27)
      • Low Molecular Weight Heparins (67)
      • Other (53)
      • Prasugrel (Effient) (50)
      • Rivaroxaban (Xarelto) (111)
      • Ticagrelor (Brilinta) (32)
      • Vorapaxar (Zontivity) (1)
      • Warfarin - Drug Interactions (37)
      • Warfarin - Treatment (162)
  • Arrhythmias (177)
  • Blood Pressure (30)
  • Cardiovascular Disease and Depression (9)
  • Cholesterol (57)
  • Dyslipidemia (270)
  • Endocarditis (20)
  • Heart Disease (78)
  • Heart Failure (183)
  • Hypertension (303)
  • Hypotension (19)
  • Ischemic Heart Disease/Acute Coronary Syndromes (354)
  • Myocardial Infarction (42)
  • Peripheral Vascular Disease (9)
  • Pulmonary Arterial Hypertension (1)
  • Raynaud's (1)
  • Resources (901)
  • Stroke (170)
46 - 53 of 53 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: whether Pradax (dabigatran) will replace warfarin in patients with atrial fibrillation October 2009
Article: Xarelto (zah-rel-toe) is the latest ORAL anticoagulant to hit the Canadian market November 2008
Article: Pradax (dabigatran etexilate) to compete with warfarin and heparins August 2008
Article: what to do about aspirin, clopidogrel, NSAIDs, and warfarin when patients need surgery August 2008
Commentary: Managing Warfarin & Antiplatelet Drugs Perioperatively August 2008
Guideline: ACCP Antithrombotic and Thrombolytic Guidelines, 8th edition. Executive Summary August 2008
Article: heparin recall rekindles concern over the safety of drugs made overseas May 2008
Commentary: LMWH Dosing in Obesity February 2008
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved